Filtered By:
Drug: Docetaxel
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 2210 results found since Jan 2013.
Analgesic efficacy of median nerve stimulation in mice with chemotherapy-induced peripheral neuropathymodulation of brain-derived neurotrophic factor expression
CONCLUSIONS: LFMNS might be an effective non-pharmaceutical option for treating patients suffering from CIPN regulating the expression of peripheral and central BDNF.PMID:37454253 | PMC:PMC10320447 | DOI:10.19852/j.cnki.jtcm.2023.04.005
Source: Journal of Traditional Chinese Medicine - July 16, 2023 Category: Complementary Medicine Authors: Dong-Wook Kang Jae-Gyun Choi Hee Ju Song Jaehyuk Kim Miae Lee Taehee Kim Suk-Yun Kang Yeonhee Ryu Hwa Seung Yoo Jin Sun Lee Jin Bong Park Sang Do Lee Hyun-Woo Kim Source Type: research
Novel Approaches in the Systemic Management of High-Risk Prostate Cancer
Clin Genitourin Cancer. 2023 Jun 18:S1558-7673(23)00140-4. doi: 10.1016/j.clgc.2023.06.001. Online ahead of print.ABSTRACTLocally advanced prostate cancer comprises approximately 20% of new prostate cancer diagnoses. For these patients, international guidelines recommend treatment with radiotherapy (RT) to the prostate in combination with long-term (2-3 years) androgen deprivation therapy (ADT), or radical prostatectomy in combination with extended pelvic lymph node dissection (PLND) as another treatment option for selected patients as part of multimodal therapy. Improvements in overall survival with docetaxel or an androg...
Source: Clinical Prostate Cancer - July 15, 2023 Category: Cancer & Oncology Authors: Maria Antonia G ómez-Aparicio Fernando L ópez-Campos Antonio Jos é Lozano Xavier Maldonado Bego ña Caballero Juan Zafra Vladamir Suarez Elena Moreno Stefano Arcangeli Marta Scorsetti Felipe Cou ñago Source Type: research
Simultaneously metastatic cholangiocarcinoma and small intestine cancer from breast cancer misdiagnosed as primary cholangiocarcinoma: A case report
CONCLUSION: Simultaneous metastatic cholangiocarcinoma and small intestine cancer from breast cancer are rare and the prognosis is extremely poor. Improving preoperative diagnostic accuracy is beneficial to avoid excessive surgical treatment. Treatment should be aimed at relieving biliary obstruction and abdominal pain, and then supplemented with chemotherapy and targeted therapy to control tumor progression and prolong the patient's life.PMID:37449239 | PMC:PMC10336993 | DOI:10.12998/wjcc.v11.i18.4446
Source: Clinical Genitourinary Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Xin Jiao Mi-Mi Zhai Fang-Zhou Xing Xiao-Ling Wang Source Type: research
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
This study demonstrates that RM-581 could be effective for the treatment of BC, especially TNBC.PMID:37445276 | DOI:10.3390/jcm12134241
Source: Clinical Genitourinary Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Anna Burguin Jenny Roy Genevi ève Ouellette Ren é Maltais Juliette Bherer Caroline Diorio Donald Poirier Francine Durocher Source Type: research
Simultaneously metastatic cholangiocarcinoma and small intestine cancer from breast cancer misdiagnosed as primary cholangiocarcinoma: A case report
CONCLUSION: Simultaneous metastatic cholangiocarcinoma and small intestine cancer from breast cancer are rare and the prognosis is extremely poor. Improving preoperative diagnostic accuracy is beneficial to avoid excessive surgical treatment. Treatment should be aimed at relieving biliary obstruction and abdominal pain, and then supplemented with chemotherapy and targeted therapy to control tumor progression and prolong the patient's life.PMID:37449239 | PMC:PMC10336993 | DOI:10.12998/wjcc.v11.i18.4446
Source: Clinical Breast Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Xin Jiao Mi-Mi Zhai Fang-Zhou Xing Xiao-Ling Wang Source Type: research
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
This study demonstrates that RM-581 could be effective for the treatment of BC, especially TNBC.PMID:37445276 | DOI:10.3390/jcm12134241
Source: Clinical Breast Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Anna Burguin Jenny Roy Genevi ève Ouellette Ren é Maltais Juliette Bherer Caroline Diorio Donald Poirier Francine Durocher Source Type: research
Simultaneously metastatic cholangiocarcinoma and small intestine cancer from breast cancer misdiagnosed as primary cholangiocarcinoma: A case report
CONCLUSION: Simultaneous metastatic cholangiocarcinoma and small intestine cancer from breast cancer are rare and the prognosis is extremely poor. Improving preoperative diagnostic accuracy is beneficial to avoid excessive surgical treatment. Treatment should be aimed at relieving biliary obstruction and abdominal pain, and then supplemented with chemotherapy and targeted therapy to control tumor progression and prolong the patient's life.PMID:37449239 | PMC:PMC10336993 | DOI:10.12998/wjcc.v11.i18.4446
Source: Clinical Genitourinary Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Xin Jiao Mi-Mi Zhai Fang-Zhou Xing Xiao-Ling Wang Source Type: research
Feasibility of cabazitaxel in octogenarian prostate cancer patients
CONCLUSIONS: Octogenarian patients can be treated with cabazitaxel with reduced doses or alternative schedules that are associated with less toxicity and fewer treatment interruptions. Comprehensive geriatric assessment could facilitate more appropriate patient selection.PMID:37448615 | PMC:PMC10337820 | DOI:10.1097/CU9.0000000000000081
Source: Cancer Control - July 14, 2023 Category: Cancer & Oncology Authors: Paolo Tralongo Sebastiano Bordonaro Giuseppe Di Lorenzo Ugo De Giorgi Nicol ò Borsellino Gaetano Facchini Sabrina Rossetti Giuseppe Fornarini Vito Longo Antonino Carmelo Tralongo Francesca Caspani Massimiliano Spada Nicola Calvani Paolo Carlini Source Type: research
Simultaneously metastatic cholangiocarcinoma and small intestine cancer from breast cancer misdiagnosed as primary cholangiocarcinoma: A case report
CONCLUSION: Simultaneous metastatic cholangiocarcinoma and small intestine cancer from breast cancer are rare and the prognosis is extremely poor. Improving preoperative diagnostic accuracy is beneficial to avoid excessive surgical treatment. Treatment should be aimed at relieving biliary obstruction and abdominal pain, and then supplemented with chemotherapy and targeted therapy to control tumor progression and prolong the patient's life.PMID:37449239 | PMC:PMC10336993 | DOI:10.12998/wjcc.v11.i18.4446
Source: Clinical Breast Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Xin Jiao Mi-Mi Zhai Fang-Zhou Xing Xiao-Ling Wang Source Type: research
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
This study demonstrates that RM-581 could be effective for the treatment of BC, especially TNBC.PMID:37445276 | DOI:10.3390/jcm12134241
Source: Clinical Breast Cancer - July 14, 2023 Category: Cancer & Oncology Authors: Anna Burguin Jenny Roy Genevi ève Ouellette Ren é Maltais Juliette Bherer Caroline Diorio Donald Poirier Francine Durocher Source Type: research
